Wugen

Last updated: August 28, 2025

CEO - Kumar Srinivasan
CEO - Kumar Srinivasan
USA | Funding: $172M (+)

Website: https://wugen.com/

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies